Analysts caution that while SNDL stock price is supported by technical strength, macroeconomic risks like tighter monetary policy could temper upside in speculative sectors. An essential component of medical marijuana, CBD is the legal, non-psychoactive compound that is used to treat chronic pain, anxiety, and other ailments. Though initially met with skepticism, medical cannabis is rapidly gaining traction in the United States and as of the writing of this article, the use of marijuana for medical purposes is legal in 39 states, in addition to the District of Columbia. The latest state to join the growing list was Nebraska, which voted to legalize and regulate medical cannabis in November 2024. Over the past two months, 1 earnings estimate moved higher compared to none lower for the full year. This revision helped boost SNDL's consensus estimate, increasing from -$0.11 to -$0.02 in the past 60 days. Looking at the next fiscal year, 1 estimate has moved upwards while there have been no downward revisions in the same time period. SNDL stock price recently saw a crossover in MACD indicators on the daily chart, hinting at possible sustained bullish momentum, especially if volume confirms the move.